Clinical Trial

A Real-world Study of Adebrelimab-based Combination Regimens in the Treatment of Advanced Solid Tumors

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This prospective, multicenter, non-interventional, observational, real-world study was designed to evaluate the safety and efficacy of an adebrelimab-based regimen in patients with advanced solid tumors.
Trial Details
NCT Number NCT07173244
Lead Sponsor Tianjin First Central Hospital
Conditions Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Gastrointestinal Cancers
Enrollment 300 participants
Start Date 2025-09-15
Primary Completion 2027-09 (estimated)
Study Completion 2029-09 (estimated)
Updated on ClinicalTrials.gov 2025-09-15